Does TRILACICLIB Cause Off label use? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Off label use have been filed in association with TRILACICLIB (COSELA). This represents 11.1% of all adverse event reports for TRILACICLIB.
25
Reports of Off label use with TRILACICLIB
11.1%
of all TRILACICLIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Off label use From TRILACICLIB?
Of the 25 reports, 1 (4.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Myelosuppression (24)
Dyspnoea (18)
Pneumonia (18)
White blood cell count decreased (18)
Platelet count decreased (17)
Anaemia (15)
Performance status decreased (14)
Death (13)
Infection (12)
Haemorrhage (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TRILACICLIB Alternatives Have Lower Off label use Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE